News and Media

Latest News Release
09/28/2023

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

TerraPower and Cardinal Health announce manufacturing and distribution agreement for Actinium-225
08/12/2021

Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce Actinium-225, which will be utilized in drug trials involving targeted alpha therapy for diseases such as breast, prostate, colon and neuroendocrine cancers, melanoma and lymphoma. Learn more in today’s press release

More Company News
09/28/2023

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

09/26/2023

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company...

09/13/2023

Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio, Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in...

08/30/2023

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral...

View all company news »